ReviewImmunoTargets and therapy2026
Role of Cytokines in Bone Diseases and Their Therapeutic Application.
Review in ImmunoTargets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone tissue is comprised of three primary cell types: osteoclasts, the bone resorbing cells; osteoblasts, the bone forming cells; and osteocytes, the cell type involved in mechanotransduction. Osteoclasts are multinucleated cells of hematopoietic origin that degrade bone, while osteoblasts arise from mesenchymal stem cells to synthesize bone matrix. Osteocytes, differentiated from osteoblasts, sense mechanical strain, coordinate with osteoclasts and osteoblasts, and regulate bone remodeling. Cytokines produced during immune responses to infections and autoimmune diseases significantly influence bone homeostasis and metabolism. This review elucidates the roles of both pro- and anti-inflammatory cytokines in bone cell differentiation and function, including their activation of downstream epigenetic and metabolic pathways underlying bone remodeling. Additionally, we discussed how we can exploit these cytokines therapeutically to manage infection or inflammatory diseases related to bone diseases and disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.